Kerry, a world leader in taste and nutrition, has announced a new commercial agreement with Japan-based Kameda Seika to market and distribute the company’s rice-derived postbiotic exclusively in Americas and Europe across a range of applications. Kameda’s postbiotic Lactobacillus K-1 (Lactobacillus casei subsp, 327) has been scientifically proven to improve both[Read More…]